Multiplex Assay Kit for Plasminogen Activator, Urokinase Receptor (uPAR) ,etc. by FLIA (Flow Luminescence Immunoassay)

CD87; PLAUR; PLAU-R; U-PAR; URKR; Monocyte Activation Antigen Mo3

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Plasminogen Activator, Urokinase Receptor (uPAR) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Plasminogen Activator, Urokinase Receptor (uPAR) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Plasminogen Activator, Urokinase Receptor (uPAR) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Plasminogen Activator, Urokinase Receptor (uPAR) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 83-90 86
EDTA plasma(n=5) 79-101 82
heparin plasma(n=5) 91-99 94

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Plasminogen Activator, Urokinase Receptor (uPAR) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Plasminogen Activator, Urokinase Receptor (uPAR) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Plasminogen Activator, Urokinase Receptor (uPAR) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 78-89% 92-99% 98-105% 96-103%
EDTA plasma(n=5) 80-91% 81-102% 80-98% 86-101%
heparin plasma(n=5) 83-98% 97-105% 78-92% 82-92%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:uPAR) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
International Journal of Cancer Dietary supplementation with methylseleninic acid, but not selenomethionine, reduces spontaneous metastasis of Lewis lung carcinoma in mice Wiley: source
Biomark Insights Decreased Epidermal Growth Factor (EGF) Associated with HMGB1 and Increased Hyperactivity in Children with Autism PubMed: PMC3623607
Biomarker insights Decreased Hepatocyte Growth Factor (HGF) and Gamma Aminobutyric Acid (GABA) in Individuals with Obsessive-Compulsive Disorder (OCD) PubMed: PMC3762604
Am J Emerg Med Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis PubMed: 26615223
Archives of Clinical Infectious Diseases Evaluation of Diagnostic Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Sepsis Archcid: 26346
The American Journal of Emergency Medicine Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic Cavia (Guinea pig )idance of sepsis science:S0735675715009559
Journal of Clinical and Experimental Hepatology Evaluation of Plasma Urokinase-Type Plasminogen Activator Receptor (UPAR) in Patients With Chronic Hepatitis B, C and Non-Alcoholic Fatty Liver Disease (NAFLD) … 10.1016:j.jceh.2018.02.001
Turkish journal of trauma & emergency surgery The diagnostic value of serum urokinase-type plasminogen activator receptor in acute appendicitis Pubmed: 31475329
CELL TRANSPLANTATION Predictive Value of Degranulating Factors of Neutrophils in Massive Cerebral Infarction 33787356
Catalog No. Related products for research use of Mus musculus (Mouse) Organism species Applications (RESEARCH USE ONLY!)
RPA141Mu01 Recombinant Plasminogen Activator, Urokinase Receptor (uPAR) Positive Control; Immunogen; SDS-PAGE; WB.
APA141Mu01 Active Plasminogen Activator, Urokinase Receptor (uPAR) Cell culture; Activity Assays.
RPA141Mu02 Recombinant Plasminogen Activator, Urokinase Receptor (uPAR) Positive Control; Immunogen; SDS-PAGE; WB.
PAA141Mu01 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (uPAR) WB; IHC; ICC; IP.
PAA141Mu02 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (uPAR) WB; IHC; ICC; IP.
LAA141Mu71 Biotin-Linked Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (uPAR) WB; IHC; ICC.
LAA141Mu81 FITC-Linked Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (uPAR) WB; IHC; ICC; IF.
SEA141Mu ELISA Kit for Plasminogen Activator, Urokinase Receptor (uPAR) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA141Mu Multiplex Assay Kit for Plasminogen Activator, Urokinase Receptor (uPAR) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.